Arcalyst 160 mg/2mL
rilonacept · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Kiniksa Pharmaceuticals (UK), Ltd.
Arcalyst (rilonacept) is a prescription injection used to treat rare inflammatory conditions, particularly cryopyrin-associated periodic syndromes (CAPS). It works by blocking inflammatory proteins in the body and is administered as a subcutaneous injection.
Key Facts
- Brand Name
- Arcalyst
- Generic Name
- rilonacept
- NDC Code (Product)
73604-914- Manufacturer
- Kiniksa Pharmaceuticals (UK), Ltd.
- Strength
- 160 mg/2mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125249
- Marketing Start
- 02/27/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is Arcalyst used for?
Arcalyst (rilonacept) is a prescription injection used to treat rare inflammatory conditions, particularly cryopyrin-associated periodic syndromes (CAPS). It works by blocking inflammatory proteins in the body and is administered as a subcutaneous injection.
Is Arcalyst a controlled substance?
Arcalyst is not classified as a controlled substance by the DEA.
What is the generic name for Arcalyst?
The generic name for Arcalyst is rilonacept. There are no other listed brand versions of rilonacept.
What is the NDC code for Arcalyst 160 mg/2mL?
The NDC (National Drug Code) for Arcalyst 160 mg/2mL is 73604-914, listed by Kiniksa Pharmaceuticals (UK), Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)